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To obtain anamnestic antibody synthesis to a second antigenic stimulus the 
second antigen must share some immunogenic determinant with the primary 
sensitizing material. Generally the secondary response takes place only to the 
common determinants (1-3). Occasional animals have been reported to undergo 
a secondary antibody response to antigenic determinants specific only to the 
first antigen when injected with a cross-reacting antigen as the secondary stimu- 
lus (1, 4). While the antibodies produced appeared to be specific for the first 
antigen based on absorption of the secondary sera with the second antigen, 
the complexity of the antigens (albumins) has limited the interpretation of
these results. Albumins are multispecific antigens (5, 6) and the xtent o which 
hidden determinants of one species might cross-react with surface determi- 
nants on a cross-reacting species has not been investigated. 
An artificial haptenic group can represent a significant portion of a specific 
determinant. Subtle alterations in the spacial configuration of haptens cause 
corresponding alterations in the elicited antihapten antibodies and are dis- 
tinguishable by them (7). However, in the past most experiments designed to 
induce a specific anamnestic antihapten circulating antibody response inde- 
pendent of the cartier molecules have been unsuccessful (8-12). An exception 
was an experiment by Gold and Benedict (13) in which small increases in anti- 
p-aminobenzoic a id antibody levels were detected by hemagglutination fol- 
lowing administration of uncoupled hapten. The more common egative result 
led to the general conclusion expressed by Ovary and Benacerraf (10) that the 
antihapten-anamnestic response is controlled in part by the "immunological 
backbone" of the cartier and that for this reason the original carrier is required 
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718 CARRIER-INDEPENDENT ANTIHAPTEN RESPONSE 
to stimulate a secondary antihapten response. Recently, however, several re- 
ports indicated that this need not be the case and that it is possible for an un- 
related cartier protein to serve as a secondary hapten carrier and that such a 
combination can induce an anamnestic antihapten response which in most but 
not all cases was of limited intensity (14-18). 
The purpose of this paper is to describe fully experiments presented in a pre- 
l iminary report (15) concerning the anamnestic production of ant i -TNP (tri- 
nitrophenyl) precipitins in rabbits primed with trinitrophenyl-hemocyanin 
(TNP-KLH)  and recalled with TNP-bovine plasma albumin (TNP-BSA) or 
TNP-bov ine gamma globulin (TNP-BGG) at intervals of up to 11 months 
after priming. The resultant antihapten responses were equal in magnitude to 
those recalled by the TNP-homologons carrier conjugate and independent of 
the measurable r sponse to sensitization. 
Materials and Methods 
Prot~ins.--Hemocyanin (KLH) was obtained from the keyhole limpet Megalhura cranulala 
by the method of Campbell et al. (19). Crystalline bovine plasma lbumin (BSA) and bovine 
gamma globulin (BGG) were purchased from Armour Pharmaceutical Company, Kankakee, 
Ill. Rabbit serum albumin (RSA) was precipitated by acetic acid from pooled normal rabbit 
serum after removal of the globulins by precipitation with half-saturated ammonium sulfate. 
Precipitated albumin was dissolved and dialyzed against distilled water and concentrated 
by lyophiliTation. The protein was purified by preparative starch block electrophoresis (19). 
The material was dialyzed free of salt with distilled water, clarified by low speed centrifuga- 
tion, and lyophilized. It was judged pure by immunoelectrophoresis. 
Preparation of Conjugates.--TNP-KLH was prepared as described previously (20). Mole 
ratios of TNP to K_LH ranged from TNP6~0KLH to TNPI~KLH as indicated in the text. 
TNP-BSA was prepared as in reference 20 except that the coupling reaction between BSA 
and trinitrobenzene sulfonic acid (TNBS), the reactive form of the hapten~ was stopped by 
the addition of 10 moles of glycylglycine per mole of hapten in the reaction mixture (21). 
The conjugated protein was precipitated by the addition of cold 1 ~ acetic acid and centri- 
fuged. Borate buffer pH 8.6 (19) dissolved the precipitated conjugate. After centrifugation 
the clarified protein was passed through a Sephadex G-50 column equilibrated in borate- 
saline (19) to remove free TNBS and TNP-glycylglycine. The cycle of precipitation and gel 
filtration was repeated once or twice more until the optical density ratio at 350 m/~/280 m/~ 
of the conjugate in borate-saline was the same after two successive column passages. Mole 
ratios of TNP to BSA prepared in this manner ranged from TNPItBSA to TNPt4BSA. 
TNP-RSA was prepared similarly except that the coupling reaction was carried out in 
borate buffer pH 8.1 for 4 hr. The mole ratio of TNP to RSA was TNP~/70,000 tool wt RSA. 
TNP-BGG was prepared by reacting 0.19 g TNBS with 0.75 g BGG in 15 ml 0.1 M phos- 
phate buffer pH 7.9 at 30°C in the dark. The reaction was stopped by addition of glycyl- 
giycine as above. During coupling the protein precipitated. It was collected by centrlfugation 
and dissolved by bringing the pH to 7.9 with 0.5 ~ NaOH. The conjugate was passed through 
Sephadex G-50 equilibrated in 0.1 M phosphate-buffered saline pH 7.9. The conjugated pro- 
tein again precipitated on standing inthe cold and was used as a suspension for injection. There 
were approximately 13moles of TNP/1.6 X 105 tool wt BGG. 
In order to eliminate the possibility of contamination f one protein preparation by another 
a new Sephadex gel was used for each procedure. A single gel was never used for more than a 
single kind of protein. 
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MARVIN B. RITTENBERG AND DAN H. CAMPBELL 719 
Spectrophotometric determinations of hapten per protein were performed as in reference 
20. 
e-mono-TNP-T.-lysine was synthesized by a modification ofOkuyama nd Satake's method 
(22) using 2.4 g of T.-lysine:HC1 and 9.6 g of picryl chloride (1 chloro, 2, 4, 6 trinitrobenzene) 
obtained from Matheson, Coleman and Bell (Cincinnati, Ohio). After washing with benzene 
the product solution was adjusted to pH 3 with 6 ~ NaOH and the resulting precipitate dis- 
carded. The solution was adjusted to pH 6 with 1 N NaOH and allowed to stand for several 
hours in the cold whereupon the product crystallized. RecrystaUization was repeated twice 
at pH 6. The final product crystallized at pH 3. It was washed with absolute thanol and 
ether and dried over PsOs, mp 198-199°C. Elemental analysis, 1 calculated for the hydrochlo- 
ride C, 35.00; H, 4.41; N, 17.01; C1, 8.61; O, 35.00. Found C, 35.59; H, 4.46; N, 17.47; Cl, 
8.61; O, 35.24. 
Ant~ser~.--Adult, male, New Zealand rabbits were used. All injections were intravenous 
without adjuvants. Antigen concentrations used for injection ranged from 10 to 15 mg pro- 
tein per milliliter saline. The total dose per injection was 15 mg protein per rabbit in all but 
the first experiment inwhich four rabbits received 25 nag protein each in the initial injection. 
Sensitization i  all but one experiment consisted of two injections administered 18days apart. 
The last experiment involved a single primary injection with no boosters prior to challenge. 
Animals were bled from the ear at various intervals. Sera were stored in a freezer until tested. 
Qua~ita.li~e Pre~iiYitin Ana/ys/s.--Duplicate tests were performed as described previously 
(20). Antibody to K.LH was determined using native KLH as precipitating antigen at pH 6.9. 
The first two experiments employed TNP-BSA as precipitating antigen for measuring anti- 
hapten antibody. Although control animals do not produce measurable amounts of anti- 
TN-P-BSA when given 15 mg of TNP-BSA the possibility exists that a small portion of the 
antibody labeled anti-TNP in Fig. 1 is actually coprecipitated anti-TNP-BSA. Subsequent 
experiments employed TNP-RSA as precipitating antigen for determining anti-TNP anti- 
body recalled with TNP-BSA. 
RESULTS 
Six rabbits were challenged 120 days after the second of two sensitizing in- 
jections of TNP-KLH.  Three animals were challenged with 15 mg TNP~ KLH 
and three with 15 mg TNP12BSA. Two rabbits in each group produced meas- 
urable amounts of anti-TNP (Fig. 1). All six produced predpitins detectable 
by ring test. Only the three rabbits challenged with TNP-KLH showed an 
elevation in anti-KLH titer. In this and in all subsequent experiments prechal- 
lengc injection bleedings revealed low levels of circulating anti-K.LH precipitins 
persisting in nearly all of the rabbits as a result of previous exposure to TNP-  
KLH.  This low level was not measurable and is indicated by the points below 
I00 #g in Fig. I. Anti-TNP precipitins were not detected in any rabbit at time 
of challenge. The data indicate an anamnestic antihapten response recalled by 
the hapten-heterologous carrier complex because there was no equivalent rise 
in anti-K_LH or anti-BSA (not shown) antibody and because control rabbits do 
not respond measurably to a single intravenous injection of TNP-BSA.  
All r ing test-posit ive sera were tested for abi l i ty to flocculate by  mixing equal 
volumes of serum and ant igen and incubat ing at 37°C for 2 hr. Twofold dilu- 
z Elemental analysis performed by Elek Microanalytical Laboratories, Torrance, Calif. 
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720 CARRIER- INDEPENDENT ANTIHAPTEN RESPONSE 
tiousof antigen from 160 #g N/ml to 2.5 #g N/ml were used (19). The statement 
that certain sera did not contain measurable amounts of antibody indicates 
that they did not flocculate in this preliminary test. None of the control animals 
used in this investigation produced measurable amounts of antibody after a 
single intravenous injection of either TNP-BSA or TNP-BGG. 
In a second experiment only 37 days elapsed between the second sensitizing 
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days after second sensitizing injection. Rabbits 5-92 and 5-94 were sensitized with 15 nag each 
and rabbits 6-05 and 6-10 with 25 mg each of TNP10mKLH. Each of the four was reinjected 
18 days later with 15 nag of TNP~gKLH. The challenge injection consisted of 15 mg of either 
TNPeesKIX-I or TNPI~BSA as indicated in the figure. 
injection d TNP-KLH and challenge with 15 mg TNP13BGG. Four rabbits 
were so injected along with 10 normal control animals. While none of the con- 
trois showed antibody specific for the hapten, two of the four test rabbits did 
(Table I). A single control rabbit produced detectable precipitins to the heterol- 
ogous carrier protein BGG while three showed a response to the hapten-carrier 
complex TNP-BGG (Table III). As in the first experiment here was no car- 
responding rise in anti-KLH titer (not shown). The two recall rabbits respond- 
ing to the hapten-heterologous carrier produced significant amounts of anti- 
hapten antibody (Table II). Although there was no detectable antibody to BSA 
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MARVIN B. RITTENBERG AND DAN H. CAMPBELL 721 
the possibility was entertained that a small portion of the antibody to TNP as 
measured by TNP-BSA was actually to the hapten-protein complex TNP-BSA 
as a result of the contamination byBSA of commercially prepared BGG. To 
test this possibility hapten inhibition by the method of Pauling, Pressman, and 
Grossberg (23) was carried out on rabbit 7-59 7-day recall serum. ~-TNP-lysine 
was employed as inhibiting hapten with antigen and antibody at equivalence 
(Fig. 2). The shift in slope of the dashed line near complete inhibition suggests 
a heterogeneity which may reflect antibody directed against determinants 
TABLE I 
Ring Tests on Sera from TNP-KLH-Sensitized Rabbits* after Recall with TNP-Heterologous 
Carrier Conjugates 
Recall antigen 
TNP~aBGG 
TNPI~BSA 
Days to 
recall 
37 
77 
Day after 
recall 
7 
10 
14 
4 
7 
11 
T-BSA 
2/4§ 
2/4 
2/4 
115 
4/5 
5/5 
T-BGG 
3/4 
3/4 
3/4 
O/5 
3/5 
3/5 
Ring test antigen~ 
T-RSA BSA 
0/4 
0/4 
0/4 
0/5 
3/5 2/5 
3/5 2/5 
BGG 
0/4 
0/4 
o/4 
RSA 
o/5 
o/5 
o/5 
* TNP-BGG group sensitized with two injections of 15 nag TNP61aKLH administered 
18 days apart. TNP-BSA group sensitized as above with TNPTsoKLH. Recall injections 15 
mg each. 
:~ Antigen concentrations for ring tests 10 #g N/ml. 
§ No. positive/No, tested. The lowest concentration of anti-TNP detectable by ring test 
was 25/zg/ml as determined with dilutions of antisera of known antibody content. 
other than the hapten-lysine, perhaps TNP-N-terminal amino acid or hapten- 
BSA complex. TNP-lysine did not inhibit precipitation ofBSA-rabbit anti-BSA 
(not shown). 
A similar experiment was carried out after 77 days had elapsed between 
sensitization and heterologous recall with TNP-BSA. No response was seen in 
the control group until the 11th day after injection when precipitins to TNP- 
BSA were detected intwo rabbits. In contrast all five test animals howed anti- 
bodies to the recall antigen and in three of these there was antibody specific for 
the hapten as shown by reactivity wth TNP-RSA and TNP-BGG (Table I). 
The sera of the heterologously recalled rabbits contained 0.5-1.2 mg anti-TNP 
by the 7th day after recall (Table II). As in other experiments here were no 
detectable anti-TNP precipitins in these rabbits just prior to challenge and 
there was no increase in anti-KLH after challenge. The specificity of the anti- 
TNP produced by rabbits 8-05 and 8-14 7 days after challenge was tested by 
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722 CARRIER- INDEPENDENT ANTIHAPTEN RESPONSE 
precipitation inhibition by ~-TNP-lysine at antigen-antibody equivalence 
(Fig. 2). The heterogeneity reflected by the slope of hapten inhibition in the 
TNP-BGG recall serum (dashed line) is absent in these sera. This result tends 
to reinforce the interpretation that a small portion of the apparent anti-TNP 
recalled by TNP-BGG as tested for with TNP-BSA actually was directed 
toward some determinant other than TNP-lysine. Specificity of the recaned 
antibody as measured by TNP-RSA is dearly antihapten. 
Two additional experiments of this type were performed. The interval be- 
tween sensitization and challenge was 3 months in one experiment and 11 
months in the second. One of the groups received one sensitizing injection rather 
than two. The response to sensitizing injections was evaluated quantitatively 
TABLE II 
Antihapten Precipitin Titers in Sera of TNP-KLH-Sensitized* Rabbits aft~ Challenge with 
TNP-Heterologous Carrier Conjugates 
Recall antigen 
TNPI3BGG 
TNPld3SA 
Days to recall 
37 
77 
Rabbit No. 
7-59 
7-62 
8-05 
8-10 
8-14 
~Micrograms anti-TNP/ml serum 
Day 7 Day 10-11 
675 519 
200 169 
513 4O0 
1275 675 
500 419 
* As in Table I. 
Quantitative precipitin taters. TNP-BSA was precipitant for TNP-BGG-recalled sera. 
TNP-RSA was precipitant for TNP-BSA-recaUed sera. 
in order to see whether primary responsiveness to hapten had any effect on 
subsequent ability to respond to heterologous recall (Table IV). 
Reducing to one-half the total antigen administered at sensitization and 
limiting it to a single primary injection did not affect recall of antihapten 
adversely. Extending the time between sensitization and challenge to 11 months 
did not affect he outcome adversely either. Whether or not a rabbit responded 
well to TNP after sensitization with TNP-KLH had no bearing on its response 
to challenge with TNP-BSA. Rabbits 8-36, 8-60, and 8-61 responded poorly if 
at all to sensitization yet were good anti-TNP producers on recall. On the 
contrary, rabbits 8-37, 8-39, and 8-43 responded well to sensitization but re- 
sponded minimally or not at all to recall. 
The responses of normal animals injected with the same TNP-BSA prepara- 
tions used in the above experiments were minimal and not measurable by 
quantitative precipitation (Table III). None of the rabbits howed any reactiv- 
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MARVIN B. R ITTENBERG AND DAN H.  CAMPBELL 723 
ity with TNP-RSA and only 6/16 showed reactivity with the sensitizing anti- 
gen TNP-BSA as detected on the 10th or l l th  day. 
DISCUSSION 
These results demonstrate an anamnestic anfihapten precipitin response to 
hapten conjugated to a heterologous carrier. The amount of antihapten anti- 
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FIG. 2. Hapten inhibition of precipitation of recalled anti-TNP sera. Inhibition by e-mono- 
TNP-L-lysine. 0-4}, rabbit 7-59 challenged with 15 mg TNP-BGG 37 days after sensitiza- 
tion. Anti-TNP precipitated with TNP-BSA. O O, rabbit 8-05, and • •, rabbit 8-14 
challenged with 15 mg TNP-BSA 77 days after sensitization. Anfi-TNP precipitated with 
TN-P-RSA. 
Antisera were obtained 7 days after challenge. Inhibition was performed with antigen and 
antibody at equivalence. 
Hapten similarly added to rabbit anti-BSA-BSA mixtures did not inhibit precipitation 
(not shown). 
body so produced is comparable with that induced by the hapten-homologous 
carrier conjugate as described previously (20) and as shown here (Fig. 1). 
Absence of cross-reaction between KLH and BSA as judged by failure of 
these proteins to cross-stimulate in vivo immunological processes has been 
shown (24, 25). During this investigation additional tests were made between 
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724 CARRIER-INDEPENDENT ANTIHAPTEN RESPONSE 
high titered anti-KLH or anti-BSA sera and the haptenated heterologous pro- 
teins. As tested by passive cutaneous anaphylaxis andgel diffusion there was no 
cross-reaction. Nor was there an increase in anti-KLH titer after recall with 
either TNP-BSA or TNP-BGG. 
Carrier alone was not able to recall the antihapten response. 17 rabbits 
primed with TNP-KLH were challenged with KLH between 105 and 126 days 
after sensitization. All failed to produce detectable antihapten antibodies. 
TABLE II I  
Responses ofNormal Unsensitized Rabbits to Recall Doses of TNP-Haerologous 
Carrier Conjugates 
Antigen* 
TNPIsBGG 
TNP-BSA[I 
Day a#er 
in3eetlon T-BSA 
7 O/lO§ 
' lO O/lO 
14 0/10 
4 0/11 
7 0/16 
lO-ll 6/16 
14 4 /11  
Ring test antigen:~ 
T-BGG 
3/10 
3/10 
3/10 
0/11 
0/11 
0/11 
0/6 
T-RSA 
o/11 
o/16 
o/16 
o/11 
BSA 
O/lO 
O/lO 
O/lO 
o/11 
o/16 
1/16 
o/11 
RSA 
o/11 
o/11 
o/11 
0/6 
BGG 
1/1o 
1/lO 
1/lO 
* Single intravenous injection, 15 mg/rabbit. 
;~ As in Table I. 
§ As in Table I. 
I] Three different preparations were used, conforming to those used as recall antigens. 
TNPI,BSA and TNPlxBSA each administered to five control animals. TNP~BSA admin- 
istered to six control animals. 
Although early experiments (26-28) indicated that immunologic recognition of 
antigenic regions of haptenated proteins included more of the carrier in delayed than 
in immediate hypersensitivity, recent experiments (29-32) have narrowed this dis- 
tinction. Leskowitz et al. (30) showed that delayed but not immediate hypersensitivity 
reactions were elicited with arsanilate-protein in animals ensitized with arsanilate-N- 
acetyl-tyrosine indicating that a very small structural region can sensitize to delayed 
hypersensitivity. Schlossman and Levine (32) suggested that the size of the structural 
area surrounding the hapten as measured by delayed hypersensitivity reflects the 
functional region of hapten immunogenicity based on the ability of a-dinitrophenyl- 
hepta-L-lysine to both immunize and to elicit delayed hypersensitivity, functions 
which the hexapeptide lacked. Presumably the size of the region would vary with the 
materials employed. Whether the ultimate size of such an immunogenic region would 
ever be so narrow as to encompass the hapten alone is not yet dear. This is suggested, 
however, by the successful elicitation of delayed hypersensitivity b arsanilate-salmine 
in animals ensitized to arsanilate-polytyrosine (29). Salmine contains no tyrosine in- 
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MARVIN B, R ITTENBERG AND DAN H.  CAMPBELL 725 
dicating that the immunogenic haptenic determinant did not nclude specifically the 
associated amino acid. 
The experiments reported here show that immunologically recognizable 
portions of the carrier "backbone" are not required in the homologous hapten- 
heterologous carrier recall of circulating antihapten antibody. While it is 
possible that submolecular regions of imilarity occur in KLH and BSA and 
BGG these are beyond detection by present immunologic methods. Possibly 
the hapten singles out such submolecular regions. Unlike the chloride form of 
TNP, picryl chloride (which also attacks phenolic hydroxy and imidazole imino 
groups), the sulfonic acid form of TNP as used here conjugates to primary 
amino groups selectively (22). Haptenation by this method results in a more 
uniform product in which lysine accounts fornearly all of the conjugated amino 
acids except for the relatively small proportion of available N-terminal groups. 
While the immtmogenic region may be larger than the hapten and adjacent 
amino acid or may include regions linearly distant due to spatial foldings of the 
carrier, a certain degree of homogeneity is achieved by this haptenation pro- 
cedure. Whether reduced heterogeneity in the site of hapten attachment affects 
success or failure of heterologous recall is not known. If submolecular environ- 
ment plays a role in hapten immunogenicity, multiple environments on the 
sensitizing carrier could provide a better chance for finding some homologous 
environments when hapten is attached to other proteins. From a selective point 
of view, however, homogeneity of hapten attachment would result presumably 
in a reduced spectrum ofcells responding to sensitization. In this sense prolifera- 
tion of a narrower class of antihapten-specific cells might help to magnify the 
recall response when the hapten is presented on a carrier providing the proper 
environment. I  should be noted that thus far attempts to recall anti-TNP 
with mono-TNP-bovine-insul~n have failed. 2 In this case insulin provided a very 
homogeneous environment with but a single lysine located on the B chain 
accounting for approximately 95% of the hapten. The remaining hapten was 
found on the N-terminal amino acids glycine and phenylalanine. Since insulin 
is a weak immunogen thereason for failure cannot be attributed directly to the 
hapten-carrier structural relationship. Other proteins or peptides of known 
structure and greater ~mmunogenicity may offer a better means of testing this 
aspect of heterologous recall. 
While all of the animals responded to heterologous recall when challenged 
11 months after sensitization it was possible also to obtain significant recall 
after only 37 days had elapsed between sensitization and challenge. Although 
the groups were small the proportion of positive responders (approximately 
50 %) was the same at challenge intervals lying between 37 days and 11 months. 
Therefore, while a very lengthy interval may enhance the ability of some ani- 
2 Rittenberg, M.B. Unpublished observations. 
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726 CARRIER- INDEPENDENT ANTH~APTEN RESPONSE 
mals to respond it is not an absolute requirement as was suggested by similar 
experiments employing pneumococcus and pneumococcal polysaccharide as 
sensitizing immunogen and challenging hapten respectively (18). These varia- 
tions in time of successful recall may reflect differences in the fundamental 
immunogenicities of the materials employed as well as differences in size of 
individual cell populations capable of responding to a particular stimulus. They 
TABLE IV 
Comparison of Response to Sensitization by TNP-KLH and Subsequent Ability to Respond 
to Haerologous Recall by TNP-BSA 
Rabbit 
No. 
8-36 
8-37 
8-38 
8-39 
8-42 
8-43 
8-57 
8-58 
8-59 
8-60 
8-61 
Sensitizing injections 
15 mg 
Ts~KLH 
15 mg 
Tlo~KLH 
15 mg 
TgeoKLH 
None 
4 
o! 
294 
294 
481 
Microgram anti-TNP*/ml serum 
Da~¢ after last 
sensittzing injection 
I 
o 0121 I 
556] 
~251I I ] 
275 
z7511 1 / 
t63 ] 
o 1so 1115 1so I 
0269 244 306 
+ +1144 119 I 
0 +[+ 131 / 
o I o10 
Da~r after recall 
injection }ays to 
'ecallt 
6-8 10 14. 
444 306[ 219 
O] O~ 0 
92 17~ +1471 ++ 
638111 6~ 531 
o + 
806 j 606 456 
i 188 131 
333 225 147 + 
225 394 300 
394 256 + 
I 
* Anti-TNP as measured by quantitative precipitation using TNP-BSA as precipitant 
before recall; TNP-RSA as precipitant after recall. 
8-36 through 8-43 recalled with 15 mg TNP13BSA. 8-57 through 8-61 recalled with 
TNPnBSA. 
§ 0, antibody not detectable by ring test. +, antibody detectable by ring test but amount 
insufficient to measure (see text). 
]I Antibody values after absorption of complement and onspecific factors by treatment 
with washed heterologous antigen-antibody complexes (20). 
may also reflect the suppressive effects of residual antihapten antibody (33). 
Although these experiments were carried out after anti-TNP precipitins had 
disappeared, ring testing is too insensitive a method to insure that all animals 
had the same residual level of circulating anti-TNP at the time of recall. 
These studies were undertaken i itially because TNP-KLH had proved to be 
a potent immunogen which does not require adjuvant in order to elicit early 
precipitating antihapten antibody (20). It was felt that previous failures to 
demonstrate anamnestic antihapten responses independent of the carrier (8-12) 
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MARVIN B. R ITTENBERG AND DAN H. CAMPBELL  727 
may have been due to weaker immunogenic stimuli and that TNP-KLH could 
overcome this deficiency. The data in Table IV which show no correlation 
between anti-TNP response after primary sensitization and subsequent abil- 
ity to be challenged successfully by TNP-heterologous carrier conjugate 
indicate that potent immunogenicity of primary sensitization does not 
guarantee successful recall. Perhaps circulating antibody levels do not reflect 
the extent of sensitization. Although antihapten titer presumably parallels the 
size of the cell population producing specific antihapten antibody, the correla- 
tion may be too gross to provide a satisfactory index of sensitization, particu- 
larly if only certain subpopulations of cells producing antihapten antibody will 
respond when the challenging hapten is on a heterologous carrier. If the latter 
were the case however, the heterologously recalled response would not be 
expected to equal the homologous response quantitatively yet it did in many 
animals. The response of some cells to sensitization may be proliferative but 
nonantibody producing until a second antigenic ontact occurs. Whereas others 
may respond irectly to sensitization and produce antibody or continue pro- 
liferation to a stage where they respond to persisting primary antigen (34). 
These experiments differed from others mainly in the use of a primary 
immunogen, TNP-KLH, which did not require adjuvant o elicit a primary 
antihapten response. Elimination of adjuvants made possible recall experi- 
ments at a time when antihapten antibodies were no longer detectable. In the 
other reported successful experiment in which recall responses were deter- 
mined quantitatively antihapten fiters only increased to twice the prerecall 
level and adjuvant was used during sensitization (18). Suppression by persisting 
antihapten antibody could have been the reason for failure or low level responses 
in that experiment although it did not suppress control animals injected with 
homologous conjugates. Presumably if persisting antibody were suppressing, 
then the greater the response to sensitization the greater would be the chance 
for suppression; the frequency of successful heterologous recall should be 
inversely proportional to primary response. The data in Table IV do not allow 
such a conclusion. There is no distinct correlation in either direction. 
These experiments show that large immunologically identifiable regions of 
the primary carrier molecule are not required to elicit a sizeable secondary 
antihapten precipitin response. Immunologically unrelated proteins may serve 
as hapten carriers for heterologous recall of antihapten. The extent o which 
regions of submolecular homology between primary and secondary carrier 
contribute to antihapten recall remains to be determined. 
SlYMM.ARY 
Anamnestic antihapten responses were obtained to trinitrophenyl (TNP) 
when rabbits sensitized to trinitrophenyl-hemocyanin (TNP-KLH) were 
challenged with TNP-heterologous protein conjugates. Hapten-heterologous 
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carrier conjugates elicited antihapten titers similar in magnitude to those 
elicited by the homologous carrier conjugate. Hapten-heterologous carrier 
recall of antihapten was successful as early as 37 days and as late as 11 months 
after sensitization. There was no correlation between anti-TNP-precipitating 
antibody titer after sensitization and the ability to respond to challenge by 
hapten-heterologous carrier. The results are discussed in terms of immuno- 
genicity of sensitization, suppressive effects of persisting postsensitization a ti- 
body, and submolecular haptenic environment as factors possibly affecting the 
heterologous recall process. 
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